Consumer telehealth and wellness brand Hims & Hers came out on top of its projections for the first quarter of 2021, according to its financial results report released today.
In its report from Q4 2020, Hims & Hers estimated its revenue to total between $48 million and $50 million, while adjusted EBITDA was expected to land within -$9.5 million and -$11.5 million.
“Building on our...
Despite coming out on top of analysts’ revenue predictions, Dexcom’s stock is tumbling after the company shared its first quarter of 2021 financial results.
As of Friday afternoon, Dexcom’s stock has fallen 6.3% from about $422 to $395.
Still, the company posted year-over-year growth for Q1 and increased its expectations for the remainder of the year.
“Dexcom is off to a great start in 2021,...
